Policy | October 09, 2021
ASU drug manufacturing licence goes online
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
This opens up a huge market for the company’s Magnezis implants in India
It adds Rezurock (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)
This facility will integrate with existing Max hospitals and create a 2,300-bed contiguous medical hub spread over 23 acres. The first phase is to be ready by 2024
Advances deployment of mRNA technology across vaccines and therapeutics development
It works as an adjunct to standard care based on robust clinical trials
Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office
Presently, IMPCL is manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for the various diseases spectrum
Besides powering the drug discovery efforts, phytopharmaceuticals have a huge potential to create a niche market for itself, thereby helping to expand the bio-economy.
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
Subscribe To Our Newsletter & Stay Updated
